Clinical Trials Logo

Clinical Trial Summary

Schistosomiasis is a chronic infection endemic in 74 tropical and sub-tropical countries. Sub-Saharan Africa carries the highest burden (90%) of schistosomiasis which caused by both Schistosoma mansoni and Schistosoma haematobium. The prevalence of Schistosomiasis should be assessed to control of the infection. This is usually achieved through surveys based on the use of traditional parasitological methods as urine filtration for S. haematobium. However, these traditional methods are time consuming, require an experienced technician and multiple samples due to light-infection and irregular shedding. Therefore, the point-of-care Circulating Cathodic Antigen (POC-CCA) urine test has been developed for the diagnosis of S. haematobium infection which is simple, rapid, sensitive and specific assay.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05276414
Study type Observational
Source Sohag University
Contact Asmaa K Abd Ellah, lecturer
Phone 01067123632
Email Asmaakamal@med.sohag.edu.eg
Status Recruiting
Phase
Start date March 15, 2022
Completion date October 30, 2022